Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

High cutoff versus high-flux haemodialysis for myeloma cast nephropathy in patients receiving bortezomib-based chemotherapy (EuLITE): a phase 2 randomised controlled trial.

Hutchison CA, Cockwell P, Moroz V, Bradwell AR, Fifer L, Gillmore JD, Jesky MD, Storr M, Wessels J, Winearls CG, Weisel K, Heyne N, Cook M.

Lancet Haematol. 2019 Apr;6(4):e217-e228. doi: 10.1016/S2352-3026(19)30014-6. Epub 2019 Mar 11.

PMID:
30872075
2.

Intravenous Iron in Patients Undergoing Maintenance Hemodialysis.

Macdougall IC, White C, Anker SD, Bhandari S, Farrington K, Kalra PA, McMurray JJV, Murray H, Tomson CRV, Wheeler DC, Winearls CG, Ford I; PIVOTAL Investigators and Committees.

N Engl J Med. 2019 Jan 31;380(5):447-458. doi: 10.1056/NEJMoa1810742. Epub 2018 Oct 26. Erratum in: N Engl J Med. 2019 Jan 14;:.

PMID:
30365356
3.

Randomized Trial Comparing Proactive, High-Dose versus Reactive, Low-Dose Intravenous Iron Supplementation in Hemodialysis (PIVOTAL): Study Design and Baseline Data.

Macdougall IC, White C, Anker SD, Bhandari S, Farrington K, Kalra PA, McMurray JJV, Murray H, Steenkamp R, Tomson CRV, Wheeler DC, Winearls CG, Ford I; on behalf of the PIVOTAL Trial investigators.

Am J Nephrol. 2018;48(4):260-268. doi: 10.1159/000493551. Epub 2018 Oct 10.

4.

Declining comorbidity-adjusted mortality rates in English patients receiving maintenance renal replacement therapy.

Storey BC, Staplin N, Harper CH, Haynes R, Winearls CG, Goldacre R, Emberson JR, Goldacre MJ, Baigent C, Landray MJ, Herrington WG.

Kidney Int. 2018 May;93(5):1165-1174. doi: 10.1016/j.kint.2017.11.020. Epub 2018 Feb 12.

5.

Biliary Tract and Liver Complications in Polycystic Kidney Disease.

Judge PK, Harper CHS, Storey BC, Haynes R, Wilcock MJ, Staplin N, Goldacre R, Baigent C, Collier J, Goldacre M, Landray MJ, Winearls CG, Herrington WG.

J Am Soc Nephrol. 2017 Sep;28(9):2738-2748. doi: 10.1681/ASN.2017010084. Epub 2017 May 2.

6.

A proposal for standardized grading of chronic changes in native kidney biopsy specimens.

Sethi S, D'Agati VD, Nast CC, Fogo AB, De Vriese AS, Markowitz GS, Glassock RJ, Fervenza FC, Seshan SV, Rule A, Racusen LC, Radhakrishnan J, Winearls CG, Appel GB, Bajema IM, Chang A, Colvin RB, Cook HT, Hariharan S, Herrera Hernandez LP, Kambham N, Mengel M, Nath KA, Rennke HG, Ronco P, Rovin BH, Haas M.

Kidney Int. 2017 Apr;91(4):787-789. doi: 10.1016/j.kint.2017.01.002.

PMID:
28314581
7.

Long-term effects of lithium on renal function.

Judge PK, Winearls CG.

Lancet. 2015 Nov 14;386(10007):1942-3. doi: 10.1016/S0140-6736(15)00831-4. Epub 2015 Nov 13. No abstract available.

PMID:
26841746
8.

Mayo Clinic/Renal Pathology Society Consensus Report on Pathologic Classification, Diagnosis, and Reporting of GN.

Sethi S, Haas M, Markowitz GS, D'Agati VD, Rennke HG, Jennette JC, Bajema IM, Alpers CE, Chang A, Cornell LD, Cosio FG, Fogo AB, Glassock RJ, Hariharan S, Kambham N, Lager DJ, Leung N, Mengel M, Nath KA, Roberts IS, Rovin BH, Seshan SV, Smith RJ, Walker PD, Winearls CG, Appel GB, Alexander MP, Cattran DC, Casado CA, Cook HT, De Vriese AS, Radhakrishnan J, Racusen LC, Ronco P, Fervenza FC.

J Am Soc Nephrol. 2016 May;27(5):1278-87. doi: 10.1681/ASN.2015060612. Epub 2015 Nov 13.

9.

The utility of magnetic resonance imaging in the diagnosis of chronic lithium nephropathy.

Judge PK, Winearls CG.

QJM. 2015 Jan;108(1):75-6. doi: 10.1093/qjmed/hcu138. Epub 2014 Jun 26. No abstract available.

PMID:
24970763
10.

Donor transmission of Cryptococcus neoformans presenting late after renal transplantation.

MacEwen CR, Ryan A, Winearls CG.

Clin Kidney J. 2013 Apr;6(2):224-7. doi: 10.1093/ckj/sft006. No abstract available.

11.

Does prophylactic anticoagulation reduce the risk of femoral tunneled dialysis catheter-related complications.

Herrington WG, Nye HJ, Haynes RJ, Winearls CG, Vaux EC.

J Vasc Access. 2013 Apr-Jun;14(2):135-42. doi: 10.5301/jva.5000117. Epub 2012 Nov 14.

PMID:
23172168
12.

Myeloma kidney: improving clinical outcomes?

Haynes R, Leung N, Kyle R, Winearls CG.

Adv Chronic Kidney Dis. 2012 Sep;19(5):342-51. doi: 10.1053/j.ackd.2012.03.001. Review.

PMID:
22920645
13.

Identification of gene mutations in autosomal dominant polycystic kidney disease through targeted resequencing.

Rossetti S, Hopp K, Sikkink RA, Sundsbak JL, Lee YK, Kubly V, Eckloff BW, Ward CJ, Winearls CG, Torres VE, Harris PC.

J Am Soc Nephrol. 2012 May;23(5):915-33. doi: 10.1681/ASN.2011101032. Epub 2012 Mar 1.

14.

Survival after starting renal replacement treatment in patients with autosomal dominant polycystic kidney disease: a single-centre 40-year study.

Haynes R, Kheradmand F, Winearls CG.

Nephron Clin Pract. 2012;120(1):c42-7. doi: 10.1159/000334429. Epub 2011 Dec 23.

PMID:
22205054
15.

An observational cohort study of extended dosing (once every 2 weeks or once monthly) regimens with darbepoetin alfa in patients with chronic kidney disease not on dialysis: the EXTEND study.

Galle JC, Claes K, Kiss I, Winearls CG, Herlitz H, Guerin A, Di Giulio S, Suranyi MG, Bridges I, Addison J, Farouk M.

Nephrol Dial Transplant. 2012 Jun;27(6):2303-11. doi: 10.1093/ndt/gfr677. Epub 2011 Dec 2.

16.

Classification of chronic kidney disease in the elderly: pitfalls and errors.

Winearls CG, Glassock RJ.

Nephron Clin Pract. 2011;119 Suppl 1:c2-4. doi: 10.1159/000328013. Epub 2011 Aug 10. Review.

17.

Simultaneous necrotizing glomerulonephritis and Hodgkin's lymphoma: a case report and review of the literature.

Barbour TD, Haynes RJ, Roberts IS, Winearls CG.

Nephrol Dial Transplant. 2011 Oct;26(10):3403-8. doi: 10.1093/ndt/gfr394. Epub 2011 Jul 21. Review.

PMID:
21778279
18.

Late presentation of patients with end-stage renal disease for renal replacement therapy--is it always avoidable?

Udayaraj UP, Haynes R, Winearls CG.

Nephrol Dial Transplant. 2011 Nov;26(11):3646-51. doi: 10.1093/ndt/gfr164. Epub 2011 Mar 31.

PMID:
21454353
19.

A case of bilateral renal masses: dilemmas in their evaluation and management.

Tweed EJ, Roberts IS, Cranston D, Winearls CG.

NDT Plus. 2011 Apr;4(2):126-9. doi: 10.1093/ndtplus/sfr019. No abstract available.

20.

Chronic kidney disease: the CKD-EPI equation to estimate GFR-better alchemy?

Winearls CG, Lamb EJ.

Nat Rev Nephrol. 2011 Mar;7(3):127-8. doi: 10.1038/nrneph.2010.190. Epub 2011 Feb 1. No abstract available.

PMID:
21283135
21.

Association of long-term administration of the survivin mRNA-targeted antisense oligonucleotide LY2181308 with reversible kidney injury in a patient with metastatic melanoma.

Herrington WG, Talbot DC, Lahn MM, Brandt JT, Callies S, Nagle R, Winearls CG, Roberts IS.

Am J Kidney Dis. 2011 Feb;57(2):300-3. doi: 10.1053/j.ajkd.2010.09.024. Epub 2010 Dec 21. Erratum in: Am J Kidney Dis. 2011 May;57(5):804.

PMID:
21177011
22.

Membranous nephropathy after use of UK-manufactured skin creams containing mercury.

Chakera A, Lasserson D, Beck LH Jr, Roberts IS, Winearls CG.

QJM. 2011 Oct;104(10):893-6. doi: 10.1093/qjmed/hcq209. Epub 2010 Nov 8. No abstract available.

PMID:
21062753
23.

CKD staging--evolution not revolution.

Winearls CG, Haynes R, Glassock R.

Nefrologia. 2010;30(5):493-500. doi: 10.3265/Nefrologia.pre2010.Jul.10501. No abstract available.

24.

Genetic variation of DKK3 may modify renal disease severity in ADPKD.

Liu M, Shi S, Senthilnathan S, Yu J, Wu E, Bergmann C, Zerres K, Bogdanova N, Coto E, Deltas C, Pierides A, Demetriou K, Devuyst O, Gitomer B, Laakso M, Lumiaho A, Lamnissou K, Magistroni R, Parfrey P, Breuning M, Peters DJ, Torra R, Winearls CG, Torres VE, Harris PC, Paterson AD, Pei Y.

J Am Soc Nephrol. 2010 Sep;21(9):1510-20. doi: 10.1681/ASN.2010030237. Epub 2010 Jul 8.

25.

Screening strategies for CKD.

Glassock RJ, Winearls CG, El Nahas M.

Nephrol Dial Transplant. 2010 Sep;25(9):3126-7; author reply 3127-9. doi: 10.1093/ndt/gfq335. Epub 2010 Jun 21. No abstract available.

PMID:
20566571
26.

Chronic kidney disease: definition and staging--an orthodox view.

Winearls CG.

Clin Med (Lond). 2009 Dec;9(6):563-4. Review. No abstract available.

27.

Presentation and survival of patients with severe acute kidney injury and multiple myeloma: a 20-year experience from a single centre.

Haynes RJ, Read S, Collins GP, Darby SC, Winearls CG.

Nephrol Dial Transplant. 2010 Feb;25(2):419-26. doi: 10.1093/ndt/gfp488. Epub 2009 Sep 19.

PMID:
19767634
28.

eGFR: Readjusting its rating.

Glassock RJ, Winearls CG.

Clin J Am Soc Nephrol. 2009 May;4(5):867-9. doi: 10.2215/CJN.01830309. No abstract available.

29.

Dissecting and refining the staging of chronic kidney disease.

Winearls CG, Glassock RJ.

Kidney Int. 2009 May;75(10):1009-14. doi: 10.1038/ki.2009.49. Epub 2009 Feb 25.

30.

Reassuring results with regard to the effect of donor nephrectomy on cardiovascular outcomes.

Haynes R, Landray MJ, Winearls CG.

Nat Clin Pract Nephrol. 2009 Mar;5(3):126-7. doi: 10.1038/ncpneph1035. Epub 2009 Jan 20.

PMID:
19153566
31.

A conversation with the Emeritus about older kidneys.

Winearls CG.

QJM. 2009 Feb;102(2):143-4. doi: 10.1093/qjmed/hcn134. Epub 2008 Dec 9. No abstract available.

PMID:
19066206
32.

Chronic kidney disease in Taiwan.

Glassock RJ, El Nahas M, Winearls CG.

Lancet. 2008 Dec 6;372(9654):1949-50; author reply 1950-1. doi: 10.1016/S0140-6736(08)61835-8. No abstract available.

PMID:
19059042
33.

Routine reporting of estimated glomerular filtration rate: not ready for prime time.

Glassock RJ, Winearls CG.

Nat Clin Pract Nephrol. 2008 Aug;4(8):422-3. doi: 10.1038/ncpneph0860. Epub 2008 Jul 1. No abstract available.

PMID:
18594501
34.

Acute renal failure secondary to oxalosis in a recipient of a simultaneous kidney-pancreas transplant: was mycophenolate the cause?

Hamidian Jahromi A, Roberts IS, Winearls CG, Vaidya A.

Nephrol Dial Transplant. 2008 Jul;23(7):2409-11. doi: 10.1093/ndt/gfn194. Epub 2008 Apr 9. No abstract available. Erratum in: Nephrol Dial Transplant. 2008 Dec;23(12):4087.. A, Hamidian Jahromi [corrected to Hamidian Jahromi, Alireza ].

PMID:
18400815
35.
36.

Proliferative glomerulonephritis associated with mantle cell lymphoma--natural history and effect of treatment in 2 cases.

Karim M, Hill P, Pillai G, Gatter K, Davies DR, Winearls CG.

Clin Nephrol. 2004 Jun;61(6):422-8. Review.

PMID:
15224806
37.

Rapidly progressive irreversible renal failure in patients with pancreatic insufficiency.

Hill P, Karim M, Davies DR, Roberts IS, Winearls CG.

Am J Kidney Dis. 2003 Oct;42(4):842-5. No abstract available.

PMID:
14520637
38.

The radical treatment of paraprotein disorders affecting the kidney.

Peniket AJ, Littlewood TJ, Winearls CG.

Nephrol Dial Transplant. 2003 Aug;18(8):1431-4. Review. No abstract available.

PMID:
12897075
39.

Association of mutation position in polycystic kidney disease 1 (PKD1) gene and development of a vascular phenotype.

Rossetti S, Chauveau D, Kubly V, Slezak JM, Saggar-Malik AK, Pei Y, Ong AC, Stewart F, Watson ML, Bergstralh EJ, Winearls CG, Torres VE, Harris PC.

Lancet. 2003 Jun 28;361(9376):2196-201.

PMID:
12842373
40.

A Christmas dialysis vignette.

Winearls CG.

Nephrol Dial Transplant. 2003 Apr;18(4):847. No abstract available.

PMID:
12637664
41.

The ENOS polymorphism is not associated with severity of renal disease in polycystic kidney disease 1.

Walker D, Consugar M, Slezak J, Rossetti S, Torres VE, Winearls CG, Harris PC.

Am J Kidney Dis. 2003 Jan;41(1):90-4.

PMID:
12500225
42.

Comparison of multilocus sequence typing and pulsed-field gel electrophoresis as tools for typing Staphylococcus aureus isolates in a microepidemiological setting.

Peacock SJ, de Silva GD, Justice A, Cowland A, Moore CE, Winearls CG, Day NP.

J Clin Microbiol. 2002 Oct;40(10):3764-70.

43.

A complete mutation screen of the ADPKD genes by DHPLC.

Rossetti S, Chauveau D, Walker D, Saggar-Malik A, Winearls CG, Torres VE, Harris PC.

Kidney Int. 2002 May;61(5):1588-99.

44.

The position of the polycystic kidney disease 1 (PKD1) gene mutation correlates with the severity of renal disease.

Rossetti S, Burton S, Strmecki L, Pond GR, San Millán JL, Zerres K, Barratt TM, Ozen S, Torres VE, Bergstralh EJ, Winearls CG, Harris PC.

J Am Soc Nephrol. 2002 May;13(5):1230-7.

45.

Consultant appraisal.

Winearls CG.

QJM. 2001 May;94(5):235-6. No abstract available.

PMID:
11353096
46.

Renal complications of jejuno-ileal bypass for obesity.

Mole DR, Tomson CR, Mortensen N, Winearls CG.

QJM. 2001 Feb;94(2):69-77. Review.

PMID:
11181982
47.

Mutation analysis of the entire PKD1 gene: genetic and diagnostic implications.

Rossetti S, Strmecki L, Gamble V, Burton S, Sneddon V, Peral B, Roy S, Bakkaloglu A, Komel R, Winearls CG, Harris PC.

Am J Hum Genet. 2001 Jan;68(1):46-63. Epub 2000 Dec 12.

48.

Prospects for effective treatment of AL amyloidosis?

Iggo N, Littlewood T, Winearls CG.

QJM. 2000 May;93(5):257-60. No abstract available.

PMID:
10825400
49.

Outcome following staphylococcal peritonitis.

Peacock SJ, Howe PA, Day NP, Crook DW, Winearls CG, Berendt AR.

Perit Dial Int. 2000 Mar-Apr;20(2):215-9.

PMID:
10809246
50.

Outcome following haemodialysis catheter-related Staphylococcus aureus bacteraemia.

Peacock SJ, Curtis N, Berendt AR, Bowler IC, Winearls CG, Maxwell P.

J Hosp Infect. 1999 Mar;41(3):223-8.

PMID:
10204125

Supplemental Content

Loading ...
Support Center